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ABSTRACT 
Objective: The objective of this study was to formulate and evaluate the drug release studies using Poly (ε-caprolactone) (PCL)/and Poly (R)-3-
hydroxy butyric acid (PHB) blend microspheres for controlled release of Tamoxifen, an anticancer drug. 
Methods: Poly (ε-caprolactone), Poly ((R)-3-Hydroxybutyric acid) blend microspheres were prepared through a modified Water/Oil/Water 
(W/O/W) double emulsion-solvent diffusion method using Dichloromethane as solvent. Tamoxifen (TAM), an anti Cancer drug, was used for 
encapsulation within PCL/PHB blend microspheres. Morphology, size, encapsulation efficiency and drug release from these microspheres were 
evaluated by different characterization techniques such as Fourier transform infrared spectroscopy (FT-IR), Differential scanning calorimetry(DSC), 
Scanning electron microscopy(SEM), X-ray diffraction studies(X-RD) and dissolution test studies respectively.  
Results: 
Conclusions: The research findings obtained from the studies were found to be satisfactory. It can be concluded that biodegradable polymer blend 
(PCL/PHB) microspheres can be effectively used for preparation of controlled release matrices.  
Drug loaded microspheres were analyzed by FT-IR, which indicates the interaction between drug and polymers. DSC thermograms on 
drug-loaded microspheres confirmed the polymorphism of Tamoxifen and indicated a molecular level dispersion of drug in the microspheres. SEM 
confirmed the spherical nature and smooth surface of the microspheres produced. X-RD study was performed to understand the crystalline nature 
of the drug after encapsulation into the microspheres and confirmed the complete dispersion of the drug in the polymer matrix. In-vitro release 
studies conducted in different pH which indicated a dependence of release rate on the amount of drug loading and the amount of PCL/PHB, but slow 
release rates were extended up to 12 h. Kinetic analysis of dissolution data showed a good fit in Peppas equation confirming diffusion controlled 
drug release. 
Keywords: Polycaprolactone, Poly (R)-3-Hydroxybutyric acid), Microspheres, SEM, X-RD, Drug release. 
 
INTRODUCTION 
Past few decades, biodegradable microspheres that encapsulate 
therapeutic agents (drugs, proteins and peptides) have received 
much attention for the application of controlled release over an 
extended period. Biodegradable polyesters such as PLA (poly (lactic 
acid)), PGA (poly Glycolide), PLGA (poly (lactic-co-glycolic acid)), 
PHB (poly 3-hydroxybutyrate) and PCL (polycaprolactone) have 
been widely used to formulate controlled-release delivery systems 
due to their biocompatibility [1-4]. Microencapsulation is one 
process used to control drug release and also for prolong 
therapeutic activity [5]. It is an application of a thin coating to 
individual core materials that have an arbitrary particle size range 
from 5 to 5000 µm [6]. In order to encapsulate the drug molecules 
within the microspheres based on a solvent evaporation method, 
there is basically three different approaches i. e water in oil (W/O) 
emulsion, Oil in Water (O/W) emulsion, Water in Oil in Water 
(W/O/W) double emulsion. In this the best known method is a 
W/O/W double emulsion technique which has been extensively 
used for the encapsulation of hydrophilic drugs [7].  
Poly (ε-caprolactone) (PCL) is one of the biocompatible and 
biodegradable aliphatic polyester polymers that degrades slowly 
and does not generate an acid environment like the poly lactide 
(PLA) or poly glycolide (PLG) polymers. Although the permeability 
of macromolecules in PCL is low, such low permeability may be 
sufficient for drug delivery. Other advantages of PCL include 
hydrophobicity, in vitro stability and low cost. Therefore many 
investigations have focused on the use of PCL microspheres for drug 
delivery applications [8-9]. The design and development of drug 
delivery carriers based on the blending of PCL with other polymers 
to improve the control release of drugs because of high permeability 
of PCL [10-13].  
Polyhydroxy butyrate (PHB) is a polyhydroxy alkanoate (PHA), 
a polymer belonging to the polyesters 
Tamoxifen (TAM), an estrogen receptor antagonist, is known to be a 
drug of choice for hormone sensitive breast cancer [17, 18]. 
Tamoxifen is also used for treatment of estrogen receptorpositive 
tumors in the premenopausal population [19]. Tamoxifen is 
generally administered through oral and parenteral route. 
Tamoxifen undergoes extensive hepatic metabolism after oral 
administration in humans [20]. Despite being quite effective on oral 
administration, Tamoxifen exhibits certain side effects like distaste 
for food, abdominal cramps, nausea and vomiting. However, its 
other infrequent side effects include endometrial carcinoma, ocular 
problems, and thromboembolic disorders and acquired drug 
resistance on long-term therapy [21-23]. These effects were 
reported to be dose dependent. To overcome these undesirable side 
effects, long term drug delivery is necessary in order to achieve 
optimum therapeutic outcomes for breast cancer. We have been 
class that are of interest as 
bio-derived and biodegradable polymer. Past few decades 
Polyhydroxy butyrate (PHB) and its copolymer hydroxy valerate 
(PHBV) are the most widely used Polyhydroxy alkanoate polymers 
in drug release studies [14]. The advantage of using these polymers 
is that they are completely biodegradable, inexpensive, easily 
produced by the fermentation of a variety of bacteria and degrade 
during natural biological processes, making them important for the 
production of release systems for bioactive materials [15, 16]. 
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exploring the development of drug loaded and drug free, PCL and 
PHB blend microspheres. 
In continuation of our drug release studies [13, 24-27] now we have 
developed new biodegradable non toxic microspheres with the 
different blend compositions of PCL and PHB.  
The blends are good compatible and loaded with Tamoxifen drug via 
in situ method for drug release studies. Hence, this system is new 
one, and as there were no reports on this in the literature, the 
results of this study have been presented here. 
MATERIALS AND METHODS 
Materials 
Polycapro lactone (M. Wt. 70,000–90,000), Poly [(R)-3-Hydroxy-
butyric acid], Gelatin form porcine and Tamoxifen, an anticancer drug, 
Dichloromethane was purchased from Sigma Aldrich Chemicals (St. 
Louis), USA. Double distilled water was used throughout the research 
work. 
Preparation of polycaprolactone/Poly [(R)-3-Hydroxybutyric 
acid] blend microspheres
The Tamoxifen loaded PCL/PHB microspheres were prepared by the 
w/o/w modified double emulsion solvent evaporation method. In 
this technique hydrophobic polymers and water-insoluble drugs are 
commonly used. Various concentrations of PCL (1.0, 0.8, 0.6 g) was 
first dissolved in 20 mL of dichloromethane and then 0.2 g of 
Tamoxifen was added to it. PHB with various concentrations (0.2, 
0.4, 0.5) was dissolved in water and added to above polymer drug 
solution. This solution was poured into 200 mL of purified water 
containing 1.0 or 0.5% gelatin. The dichloromethane was removed 
by stirring at 1,000 rpm at room temperature for 1 h. When 
evaporation was complete, the microspheres were collected by 
filtration on a filter paper (Whatman filter paper No 40), washed 
three times with distilled water and air-dried overnight at room 
temperature. Each formulation was prepared at least thrice and 
resulting batches were combined for characterization studies. The 
details of the formulation parameters and % of encapsulations are 
presented in table 1. 
  
 
Table 1: Formulation parameters and % of Encapsulation of the Tamoxifen loaded PCL/PHB blend microspheres 
Formulation code PCL/PHB (Wt/Wt) % of drug % of Gelatin %of Encapsulation 
PCL-PHB 1 90:10 10 1 48.76 
PCL-PHB 2 80:20 10 1 51.23 
PCL-PHB 3 70:30 10 1 54.62 
PCL-PHB 4 80:20 10 2 52.36 
PCL-PHB 5 80:20 10 0.5 49.24 
PCL-PHB 6 80:20 15 2 52.65 
PCL-PHB 7 80:20 20 2 58.28 
PCL-PHB 0 80:20 - 2 - 
 
Fourier transforms infrared (FTIR) spectroscopy studies 
FTIR spectral measurements performed with Nicolet, Model Impact 
410 (USA) instrument to confirm the cross-linking reaction between 
PCL/PHB blend microspheres. Polymeric microspheres finely 
grounded with KBr to prepare pellets under a hydraulic pressure of 
600 kg/cm2 and spectra scanned between 4,000 and 500 cm-1
Differential scanning calorimetry (DSC) analysis 
 for pure 
drug, drug loaded and without drug blend microspheres [24, 25]. 
Differential scanning calorimetric (DSC) curves were recorded on a 
TA instrument (Model: ST A, Q600 USA). The sample weighed was 
between 10 and 12 mg. The samples were heated from 50 to 500 oC 
at a heating rate of 10 o
X-ray diffraction (X-RD) studies 
C/min in nitrogen atmosphere (flow rate of 
100 µl/min) [24, 25]. 
X-RD measurement of plain drug, drug-loaded microspheres, and 
plain microspheres was recorded using a Rigaku Geiger flex 
Diffractometry (Tokyo, Japan) equipped with Ni-filtered Cu Ka 
radiation (k = 1.548 Ao). The dried microspheres of uniform 
thickness was mounted on the sample holder, and the patterns were 
recorded in the range 0o–50o
Scanning electron microscopy (SEM) studies 
 at the speed of 50/min. 
To determine the particle size and size distribution, microspheres 
were taken on a glace slide and their sizes were measured using an 
optical microscope under regular polarized light. SEM micrographs 
of microspheres under study were obtained under high resolution 
(Mag 3009 5kv) Using JOEL MODEL JSM 840A, SEM, equipped with 
phoenix energy dispersive analysis of X-ray (EDAX). 
Estimation of drug and encapsulation efficiency  
Polymer blend microspheres equivalent to 100 mg was stirred in 20 
ml of phosphate buffer solution (pH 7.4) and the drug content was 
analyzed by UV spectrophotometer (Lab India, Mumbai, India) at a 
λmax
 
 of 200 nm. Encapsulation efficiency (EE) was calculated as the 
percentage (w/w) of the theoretical drug content (Equation 1). 
Similar experiments were carried out at pH 1.2 also. Results were 
based on triplicate and the average values are compiled in table 1.  
In vitro release studies 
Dissolution was carried out using Tablet dissolution tester (Lab 
India, Mumbai, India) equipped with eight baskets. Dissolution rates 
were measured at 37±0.5 oC at constant speed of 100 rpm. Drug 
release from the microspheres was studied at 1.2 pH and also at 7.4 
pH phosphate buffer solution. At regular intervals of time, sample 
aliquots were withdrawn and analyzed using UV spectrophotometer 
(Lab India, Mumbai, India) at the fixed λmax
RESULTS AND DISCUSSION  
 value of 270 nm. After 
each sample collection, the same amount of fresh medium was 
added at the same temperature to the release medium to maintain 
the sink condition. All measurements were carried out in triplicate, 
and values were plotted with standard deviation errors [28]. 
FTIR studies 
FTIR spectra of pure drug and with and without drug of PCL/PHB 
blend microspheres are shown in fig. 1. The characteristic broad 
peak at 3,356.5 cm-1
PCL displays a characteristic absorption band at strong bands such 
as the carbonyl Stretching mode around 1727 cm
 indicates the OH stretching frequency of PCL 
and PHB.  
−1 (C=O), 
asymmetric stretching 2949 cm−1 (CH2) Symmetric stretching 2865 
cm−1 (CH2) PCL and PHB polymers. FTIR spectrum of Tamoxifen 
shows characteristic absorption bands at 3027 cm−1
Differential scanning calorimetry study 
 (=C-H 
stretching), 1507 and 1477(C=C ring stretching) and 3180 cm-1 
(-NH2). No changes in the spectrum of without drug and with drug 
loaded microspheres were evident by FTIR spectroscopy which is 
evidenced that the drug and polymers used are compatible in the 
present study. A similar result was made by Hiremath et al. [18] 
form their drug release studies. 
DSC thermograms of pure TAM (fig. 2. a), without drug loaded 
PCL/PHB blend (fig. 2. b) and drug loaded PCL/PHB blend 
microspheres (fig. 2. c and fig. 2. d) are shown in Fig.2. From the 
Rao et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 9, 95-100 
97 
literature it is noticed that pure PHB melts at 155 oC [17] where as 
pure PCL melts at around 60 oC [18]. From fig. 2(b) it is noticed that 
62 oC is the melting peak of PCL/PHB (80:20) blend microspheres. 
As the % of PCL increases in the blend composition the melting 
temperature also increases as we observed from fig. 2c and 2d 
(65 oC and70 o
 
C). This result may indicate that as the amount of PCL 
increases in the blend microspheres a significant crystallinity change 
was observed, this further indicates the miscibility between PHB 
and PCL. 
 
Fig. 1: FTIR spectrums of (a) PCL-PHB microspheres without drug 
(b) Pure drug (Tamoxifen) (c) PCL-PHB microspheres with drug 
 
The drug, TAM, exhibits a sharp peak at 122.97 o
 
C (fig. 2. a) due to 
polymorphism and melting. However, no characteristic peak of TAM 
was observed in DSC curves of the drug loaded microspheres which 
indicates that the drug was molecularly dispersed in the polymeric 
matrix. A similar reports was made by Jagadeesh et at [18], Chawla 
et al. [29] from their drug release studies. 
 
Fig. 2: DSC thermograms of (a) Pure TAM (drug) (b) PCL-PHB 
Microspheres (80:20) (Without drug) (c) Drug loaded PCL-PHB 




The SEM micrographs of TAM loaded microspheres are shown in 
Fig.3. Fig. 3(a) shows the shape of the microspheres before 
dissolution which are in spherical shape. Fig. 3(b) shows the shape 
of the microspheres after dissolution which are of the porous nature. 
As seen in fig. 3, they were spherical in shape [fig. 3(a)] and 
exhibited rough and porous surfaces [fig. 3(b)] due to higher 
concentration of drug in the microspheres. The mean particle size 
of PCL-PHB-6 formulation is around 10-20 µm. The size 
distribution is normal distribution showing 12 µm. The particle 
size analysis also supports the formation of microspheres. A 
similar observation was made by Sudhakar et al. from their drug 
release studies [13]. 
 
 
Fig. 3: SEM micrographs of TAM loaded microspheres (a) before 
dissolution (b) after dissolution 
 
X-ray diffraction studies  
X-RD study is an important characterization technique in case of 
drug delivery applications, to study the crystallinity of drug present 
in the polymer matrix. X-RD patterns of (a) pure TAM, (b) drug 
loaded microspheres, and (c) pure blend microspheres are shown in 
fig.4. X-RD pattern of pure TAM provides the clues about the 
crystallinity of drug in the microspheres. Here, the TAM drug peaks 
(fig. 3. a) are observed at 2θ of 21.2o and 28.3o and 41.5o
 
 which are 
due to crystalline nature of TAM, while in the case of drug loaded 
microspheres these peaks of the drug are not observed which 
indicate that the drug particles are dispersed at molecular level in 
the polymer matrix. A similar observation was made by Mohanty et 
al., from their drug release studies [30]. 
 
Fig. 4: XRD patterns of (a) pure TAM, (b) drug loaded 
microsphere, and (c) pure blend microspheres 
 
In-vitro release studies 
Effect of PCL/PHB blends composition and pH 
The release study of Tamoxifen (TAM) from microspheres, through 
in-vitro release experiments was carried out in gastric and intestinal 
pH conditions. Releases of TAM from microspheres with variation of 
PHB content for formulations PCL-PHB 1, PCL-PHB 2, PCL-PHB 3 at 
pH 7.4 and pH 1.2 are displayed in Figs. 5 and 6 respectively. The % 
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of cumulative release is higher in case of high amount of PHB. The 
release of TAM is higher at pH 7.4 than at pH 1.2. This can be 
explained on the basis of dissolution behavior of PHB in alkaline 
conditions. A dense polymer network formed when microspheres 
could intact with acidic medium, but in alkaline condition PHB is 
easily leaching out from the microspheres giving porous network 
structure. This is also supported on the basis of SEM picture (fig. 3) 
taken before dissolution [fig. 3(a)] and after dissolution [fig. 3(a)]. 
Porous microspheres are produced after the dissolution, suggesting 
that the incorporation of PHB into PCL indicates drug release is 
influenced by pH conditions. Based on these results we can conclude 
that the release of TAM restricts from lower at acidic pH, but 




Fig. 5: % Cumulative release of TAM through microspheres for 
different ratios of polymer composition PCL-PHB 1 (90:10), 
PCL-PHB 2 (80:20), and PCL-PHB 3 (70:30) containing 10% 
TAM at pH 7.4 
 
 
Fig. 6: % Cumulative release of TAM through microspheres for 
different ratios of polymer composition PCL-PHB 1 (90:10), 
PCL-PHB 2 (80:20), and PCL-PHB 3 (70:30) containing 10% 
TAM at pH 1.2 
 
Effect of drug content 
Fig.7 and 8 show the release profiles of TAM loaded PCL/PHB blend 
microspheres at different amounts of drug loading and at different 
pH conditions. For both pH conditions (pH 1.2 and pH 7.4) release 
data showed that formulations containing highest amount of TAM 
(30 wt%) displayed higher release rates than those containing lower 
of an amount of TAM. Formulation containing highest amount of 
TAM released 84.5 % (pH 7.4) of the total encapsulated drug. On the 
other hand, formulations containing lower amount of TAM have 
released only 77 % of TAM. Thus, sustained release was observed 
for the formulation containing the lower amount of TAM. Thus the 
release rates are slower for lower amount TAM in the matrix, 
probably due to the availability of more free void spaces through 
which a lesser number of the drug molecule will transport. The 
release of TAM is higher at pH 7.4 than at pH 1.2. This is due to the 
presence of PHB in the blend microspheres as explained earlier.  
 
 
Fig. 7: % Cumulative release of TAM through microspheres 
containing different amounts of drug PCL-PHB 4 (10%), PCL-
PHB 5 (20%), and PCL-PHB 6 (30%) at pH 7.4 
 
 
Fig. 8: % Cumulative release of TAM through microspheres 
containing different amounts of drug PCL-PHB 4 (10%), PCL-
PHB 5 (20%), and PCL-PHB 6 (30%) at pH 1.2 
 
Kinetics of In vitro release studies 
Drug-release kinetics was analyzed by plotting the cumulative 
release data versus time by fitting the data to a simple exponential 
equation [31].  
(Mt/M∞) = ktn 
Where Mt and M∞ represent the fractional drug release at time t, k is 
a constant characteristic of the drug-polymer system and ‘n’ is an 
empirical parameter characterizing the release mechanism. Using 
the least square procedure, we have calculated the values of n and k 
for all the formulations and these values are given in table 2. If n= 
0.5, the drug diffuses and release from the polymer matrix following 
a Fickian diffusion. If n>0.5, anomalous or non-Fickian drug diffusion 
occurs. If n = 1, a completely non-Fickian or case-II release kinetics is 
operative. The intermediary values ranging between 0.5 and 1.0 are 
attributed to an anomalous type diffusive transport [32].  
In the present study, the values of k and n showed a dependence on 
the blend composition, pH, and % of drug loading is given in table 2. 
The values of n for drug loading microspheres by using various 
amounts of PHB (10, 20, 30 wt%) while keeping TAM (10%) are 
ranged from 0.203 to 1.052 at pH 1.2, whereas the n values are 
ranged from 0.423 to 0.758 at pH 7.4 which indicates that this drug 
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release shows a shift of transport from Fickian to the anomalous 
type. Correlation coefficient (r) obtained while fitting the release 
data are in the range from of 0.812 to 0.947 at pH 1.2 where as r is in 
the range of 0.852 to 0.981 at pH 7.4. 
 
Table 2: Release Kinetics parameters (k, n and correlation coefficient (r) values) for different formulations 
Formulation Code pH 1.2 pH 7.4 
n r k n r k 
PCL-PHB 1 0.203 0.896 3.0457 0.423 0.852 2.2481 
PCL-PHB 2 0.356 0.785 2.8451 0.574 0.914 1.9523 
PCL-PHB 3 0.478 0.812 2.9254 0.627 0.981 1.5764 
PCL-PHB 4 0.695 0.851 0.3641 0.964 0.852 0.578 
PCL-PHB 5 0.352 0.756 1.8451 0.524 0.921 1.0352 
PCL-PHB 6 0.954 0.912 0.3681 0.714 0.924 1.2547 
PCL-PHB 7 1.052 0.947 0.3951 0.758 0.951 1.0261 
 
CONCLUSION 
Biodegradable Polycaprolactone (PCL) and Poly(3-R-hydroxybutyric 
acid) (PHB) blend microspheres were developed by Water/Oil/ 
Water double emulsion solvent evaporation method to study the 
controlled release of Tamoxifen(TAM), an anticancer drug. SEM, 
particle size analysis gave surface morphology and particle size of 
microspheres. DSC and X-RD analysis of TAM loaded microspheres 
has shown molecularly dispersed drug in the microspheres. Based 
on In vitro release studies the TAM was released in a controlled 
manner by influencing the variation of blend composition, pH, and 
drug for more than 12 h.  
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